Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BATAR: Atazanavir and Raltegravir Switch Study in HIV
NCT00931801Phase 4Completed
- Sponsor
- Community Research Initiative of New England
- Start
- Dec 2009
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raltegravir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Community Research Initiative of New England. Started Dec 2009; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00931801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00931801.